Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 1
2020 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
The Past, Present, and Future of Non-Viral CAR T Cells.
Moretti A, Ponzo M, Nicolette CA, Tcherepanova IY, Biondi A, Magnani CF. Moretti A, et al. Among authors: ponzo m. Front Immunol. 2022 Jun 9;13:867013. doi: 10.3389/fimmu.2022.867013. eCollection 2022. Front Immunol. 2022. PMID: 35757746 Free PMC article. Review.
Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells.
Magnani CF, Myburgh R, Brunn S, Chambovey M, Ponzo M, Volta L, Manfredi F, Pellegrino C, Pascolo S, Miskey C, Ivics Z, Shizuru JA, Neri D, Manz MG. Magnani CF, et al. Among authors: ponzo m. Mol Ther Oncolytics. 2023 Jul 19;30:56-71. doi: 10.1016/j.omto.2023.07.003. eCollection 2023 Sep 21. Mol Ther Oncolytics. 2023. PMID: 37583386 Free PMC article.
Erratum: Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells.
Magnani CF, Myburgh R, Brunn S, Chambovey M, Ponzo M, Volta L, Manfredi F, Pellegrino C, Pascolo S, Miskey C, Sandoval-Villegas N, Ivics Z, Shizuru JA, Neri D, Manz MG. Magnani CF, et al. Among authors: ponzo m. Mol Ther Oncolytics. 2023 Aug 20;30:150. doi: 10.1016/j.omto.2023.08.002. eCollection 2023 Sep 21. Mol Ther Oncolytics. 2023. PMID: 37654971 Free PMC article.
Self-Assembling PCL-Based Nanoparticles as PTX Solubility Enhancer Excipients.
Capasso Palmiero U, Morosi L, Lupi M, Ponzo M, Frapolli R, Zucchetti M, Ubezio P, Morbidelli M, D'Incalci M, Bello E, Moscatelli D. Capasso Palmiero U, et al. Among authors: ponzo m. Macromol Biosci. 2018 Oct;18(10):e1800164. doi: 10.1002/mabi.201800164. Epub 2018 Jul 25. Macromol Biosci. 2018. PMID: 30047229
Readily prepared biodegradable nanoparticles to formulate poorly water soluble drugs improving their pharmacological properties: The example of trabectedin.
Capasso Palmiero U, Morosi L, Bello E, Ponzo M, Frapolli R, Matteo C, Ferrari M, Zucchetti M, Minoli L, De Maglie M, Romanelli P, Morbidelli M, D'Incalci M, Moscatelli D. Capasso Palmiero U, et al. Among authors: ponzo m. J Control Release. 2018 Apr 28;276:140-149. doi: 10.1016/j.jconrel.2018.03.005. Epub 2018 Mar 7. J Control Release. 2018. PMID: 29524443
Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas.
Frapolli R, Bello E, Ponzo M, Craparotta I, Mannarino L, Ballabio S, Marchini S, Carrassa L, Ubezio P, Porcu L, Brich S, Sanfilippo R, Casali PG, Gronchi A, Pilotti S, D'Incalci M. Frapolli R, et al. Among authors: ponzo m. Clin Cancer Res. 2019 Dec 15;25(24):7565-7575. doi: 10.1158/1078-0432.CCR-19-0976. Epub 2019 Sep 3. Clin Cancer Res. 2019. PMID: 31481505 Free article.
Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide.
Matteo C, Orienti I, Eramo A, Zeuner A, Ferrari M, Passoni A, Bagnati R, Ponzo M, Bello E, Zucchetti M, Frapolli R. Matteo C, et al. Among authors: ponzo m. Pharmaceutics. 2024 Mar 12;16(3):387. doi: 10.3390/pharmaceutics16030387. Pharmaceutics. 2024. PMID: 38543281 Free PMC article.
Correction: Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas.
Frapolli R, Bello E, Ponzo M, Craparotta I, Mannarino L, Ballabio S, Marchini S, Carrassa L, Ubezio P, Porcu L, Brich S, Sanfilippo R, Casali PG, Gronchi A, Pilotti S, D'Incalci M. Frapolli R, et al. Among authors: ponzo m. Clin Cancer Res. 2020 Mar 1;26(5):1199. doi: 10.1158/1078-0432.CCR-20-0172. Clin Cancer Res. 2020. PMID: 32122930 No abstract available.